Your browser doesn't support javascript.
loading
CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation.
Heck, Clarissa; Steiner, Sophie; Kaebisch, Eva M; Frentsch, Marco; Wittenbecher, Friedrich; Scheibenbogen, Carmen; Hanitsch, Leif G; Nogai, Axel; le Coutre, Philipp; Bullinger, Lars; Blau, Igor-Wolfgang; Na, Il-Kang.
Affiliation
  • Heck C; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Steiner S; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Kaebisch EM; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Frentsch M; Berlin Institute of Health (BIH), Berlin, Germany.
  • Wittenbecher F; Berlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Scheibenbogen C; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Hanitsch LG; Berlin Institute of Health (BIH), Berlin, Germany.
  • Nogai A; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • le Coutre P; Berlin Institute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Bullinger L; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Blau IW; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Na IK; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Front Immunol ; 12: 736137, 2021.
Article de En | MEDLINE | ID: mdl-34659226
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes B / Lymphocytes T CD4/ / Transplantation de cellules souches hématopoïétiques / Antinéoplasiques alcoylants / Traitement néoadjuvant / Melphalan / Myélome multiple Type d'étude: Diagnostic_studies / Observational_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Front Immunol Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes B / Lymphocytes T CD4/ / Transplantation de cellules souches hématopoïétiques / Antinéoplasiques alcoylants / Traitement néoadjuvant / Melphalan / Myélome multiple Type d'étude: Diagnostic_studies / Observational_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Front Immunol Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Suisse